Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-023112
Filing Date
2021-03-25
Accepted
2021-03-25 20:51:55
Documents
1
Period of Report
2021-03-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2129
  Complete submission text file 0001209191-21-023112.txt   3507
Mailing Address 991C LOMAS SANTA FE #436 SOLANA BEACH CA 92121
Business Address 991C LOMAS SANTA FE #436 SOLANA BEACH CA 92121 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011
Business Address
Ansari Aseem Z. (Reporting) CIK: 0001849177 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40288 | Film No.: 21774307